A pilot study of an mHealth application for healthcare workers: poor uptake despite high reported acceptability at a rural South African community-based MDR-TB treatment program.

A pilot study of an mHealth application for healthcare workers: poor uptake despite high reported acceptability at a rural South African community-based MDR-TB treatment program.

As the South African province of KwaZulu-Natal addresses a growing multidrug-resistant tuberculosis (MDR-TB) epidemic by shifting care and treatment from trained specialty centers to community hospitals, delivering and monitoring MDR-TB therapy has presented new challenges. In particular, tracking a...

Descripció completa

Dades bibliogràfiques
Autors principals:	Krisda H Chaiyachati, Marian Loveday, Stephen Lorenz, Neal Lesh, Lee-Megan Larkan, Sandro Cinti, Gerald H Friedland, Jessica E Haberer
Format:	Article
Idioma:	English
Publicat:	Public Library of Science (PLoS) 2013-01-01
Col·lecció:	PLoS ONE
Accés en línia:	http://europepmc.org/articles/PMC3665589?pdf=render

Ítems similars

Decentralisation of MDR-TB care in rural South Africa: Overcoming the challenges through quality improvement
per: Katia Florman, et al.
Publicat: (2020-10-01)

‘ZS-MDR-TB’ versus ‘ZR-MDR-TB’: improving treatment of MDR-TB by identifying pyrazinamide susceptibility
per: Ying Zhang, et al.
Publicat: (2012-07-01)

MDR-TB TREATMENT UPDATE
per: Sean Wasserman
Publicat: (2023-05-01)

MDR TB Transmission, Singapore
per: Cynthia B.E. Chee, et al.
Publicat: (2013-07-01)

Risk factors for poor treatment outcomes in patients with MDR-TB and XDR-TB in China: retrospective multi-center investigation.
per: Shenjie Tang, et al.
Publicat: (2013-01-01)

RELATIONSHIP BETWEEN DETECTION OF TB AND TREATMENT OF MDR/XDR TB
per: V. Guseva, et al.
Publicat: (2023-08-01)

Community-based MDR-TB care project improves treatment initiation in patients diagnosed with MDR-TB in Myanmar.
per: Pyae Phyo Wai, et al.
Publicat: (2018-01-01)

Predictors of Multidrug-Resistant Tuberculosis (MDR-TB) in Sudan
per: Monadil H. Ali, et al.
Publicat: (2019-07-01)

MDR-TB patients in KwaZulu-Natal, South Africa: Cost-effectiveness of 5 models of care.
per: Marian Loveday, et al.
Publicat: (2018-01-01)

Relationship Between TB Treatment Phase and Knowledge of MDR TB with TB Patient’s Compliance
per: I Dewa Ayu Made Made Yuni
Publicat: (2017-03-01)

Management of MDR-TB at the University Hospital of Kinshasa
per: J.M.N. Kayembe, et al.
Publicat: (2014-04-01)

As Suicide Prediction With Artificial Intelligence Moves Forward, Barriers to Implementation Remain
per: Krisda H. Chaiyachati, MD, MPH, MSHP
Publicat: (2024-03-01)

Mathematical Model of MDR-TB and XDR-TB with Isolation and Lost to Follow-Up
per: F. B. Agusto, et al.
Publicat: (2015-01-01)

The incidence of TB and MDR-TB in pediatrics and therapeutic options: a systematic review
per: Sheetal Harichander, et al.
Publicat: (2022-08-01)

Heightened vulnerability to MDR-TB epidemics after controlling drug-susceptible TB.
per: Jason D Bishai, et al.
Publicat: (2010-09-01)

Prevalence and Factors Associated with Multidrug-Resistant Tuberculosis (MDR-TB) among Presumptive MDR-TB Patients in Tigray Region, Northern Ethiopia
per: Kibriti Mehari, et al.
Publicat: (2019-01-01)

A compartmental model on the effect of quarantine on MDR-TB
per: Yeketi, Ayinla Ally, et al.
Publicat: (2019)

Why has MDR-TB prevalence increased in Iran?
per: Mohsen Heidary, et al.
Publicat: (2016-12-01)

Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB
per: Noura M. Al-Mutairi, et al.
Publicat: (2019-12-01)

Analysis of multi drug resistant tuberculosis (MDR-TB) financial protection policy: MDR-TB health insurance schemes, in Chhattisgarh state, India
per: Debashish Kundu, et al.
Publicat: (2018-01-01)

Drug Susceptibility of Mycobacterium tuberculosis Beijing Genotype and Association with MDR TB
per: Jurriaan E.M. de Steenwinkel, et al.
Publicat: (2012-04-01)

The efficacy of all-oral shorter MDR-TB and pre-XDR TB treatment in Russia
per: Anna Abramchenko, et al.
Publicat: (2024-12-01)

Correction: The incidence of TB and MDR-TB in pediatrics and therapeutic options: a systematic review
per: Sheetal Harichander, et al.
Publicat: (2022-10-01)

Too Early to Cut Transportation Benefits From Medicaid Enrollees
per: Krisda H Chaiyachati, et al.
Publicat: (2018-10-01)

Correction to: Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB
per: Noura M. Al-Mutairi, et al.
Publicat: (2020-04-01)

The impact of the war in Ukraine on the prevalence of MDR/RR-TB in Poland
per: A. Nowinski, et al.
Publicat: (2025-01-01)

DESCRIPTION OF THE CAUSES OF MDR-TB AT IBNU SINA HOSPITAL GRESIK
per: Cucuk Rahmadi Purwanto, et al.
Publicat: (2022-10-01)

The Role of Adherence and Retreatment in De Novo Emergence of MDR-TB.
per: Dominique Cadosch, et al.
Publicat: (2016-03-01)

Disadvantage and the experience of treatment for multidrug-resistant tuberculosis (MDR-TB)
per: Holly A. Taylor, et al.
Publicat: (2022-12-01)

Six-Month Response to Delamanid Treatment in MDR TB Patients
per: Cathy Hewison, et al.
Publicat: (2017-10-01)

STUDI DESKRIPTIF PASIEN TB MDR DI SULAWESI SELATAN
per: Ikes Dwiastuti, et al.
Publicat: (2020-02-01)

Case Report: Kanamycin Ototoxicity and MDR-TB Treatment Regimen
per: Mantefardo B, et al.
Publicat: (2021-11-01)

Prolonged use of bedaquiline in the treatment for MDR-TB in a child
per: Marina F. Gubkina, et al.
Publicat: (2021-01-01)

Multistate Outbreak of MDR TB Identified by Genotype Cluster Investigation
per: Pennan M. Barry, et al.
Publicat: (2012-01-01)

The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimens
per: Uzma Khan, et al.
Publicat: (2019-08-01)

Treatment outcomes of patients with MDR-TB and its determinants at referral hospitals in Ethiopia.
per: Mengistu K Wakjira, et al.
Publicat: (2022-01-01)

Clinical profile and risk stratification in multidrug-resistant tuberculosis (MDR-TB) and non-MDR-TB patients: A prospective study in a tertiary care hospital
per: Kumar NS, et al.
Publicat: (2021-08-01)

Adverse events in healthy individuals and MDR-TB contacts treated with anti-tuberculosis drugs potentially effective for preventing development of MDR-TB: a systematic review.
per: Miranda W Langendam, et al.
Publicat: (2013-01-01)

Collaborative public–private initiatives targeting multidrug-resistant tuberculosis (MDR-TB) supported by the Lilly MDR-TB Partnership: experiences in 2012–2016
per: Shelby PW, et al.
Publicat: (2017-06-01)

HUBUNGAN DUKUNGAN KELUARGA DENGAN EFIKASI DIRI PENDERITA TUBERCULOSIS MULTIDRUG RESISTANT (TB-MDR) DI POLI TB-MDR RSUD IBNU SINA GRESIK
per: Mar'atul Hasanah, et al.
Publicat: (2018-12-01)